Immunoglobulin A Nephropathy -- Targeting Gut Mucosal Immunity to Modify the Course of the Disease

Did you know that immunoglobulin A nephropathy has very recently seen 2 treatments first licensed for its management?

Credit available for this activity expires: 6/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993766?ecd=bdc_podcast_libsyn_mscpedu